United States: Permanent "Doc Fix" Legislation Substitutes Merit-Based Incentive Payment System For SGR, And Contains Other Reimbursement And Compliance Changes

In addition to finally repealing the so-called sustainable growth rate methodology ("SGR") for adjusting Medicare physician payments that Congress has overridden consistently since 2004, the newly enacted Medicare Access and CHIP Reauthorization Act of 2015 (the "Act"), signed into law April 16, 2015, contains other important Medicare changes. Among other things, the Act:

  • establishes a new value-based physician payment adjustment methodology referred to as the Merit-based Incentive Payment System ("MIPS"); 
  • provides new financial incentives for physician participation in alternative payment models; 
  • continues the Children's Health Insurance Program ("CHIP") through federal fiscal year 2017; 
  • amends the Civil Monetary Penalties Law ("CMP") prohibition on hospital payments to physicians to reduce or limit care to add a significant "medically necessary" qualifier; and 
  • commissions a report for the purpose of providing options for the expansion of other hospital-physician "gainsharing" arrangements. 

Base Rate Adjustments. The Act replaces the SGR with a fixed 0.5% annual adjustment through calendar year 2019. In calendar years 2020–2025, the base rates will be maintained and physician compensation will be subject to adjustment under MIPS (described below). Beginning in 2026, physicians who receive a significant proportion of revenues through alternative payment models (described below) will receive a 0.75%increase, while physicians who do not so participate in alternative payment models will receive an increase of only 0.25%. 

Merit-Based Incentive Payment System. Under MIPS, physicians will be assigned a composite performance score, on a scale of 0–100, based on measures of quality, resource use, meaningful use of electronic health records, and clinical practice improvement activities. Specific performance metrics will include those existing under several previous Medicare physician incentive programs—the physician quality reporting system, the value-based modifier, and the meaningful use incentive program, all of which will be consolidated under MIPS, with their respective incentive payments to sunset in 2018 and be replaced in subsequent years by MIPS adjustments—and others to be developed by the U.S. Department of Health and Human Services ("HHS"). A threshold performance score will be set annually by HHS at the mean or median of all composite scores for a prior annual performance period. Performance exceeding the threshold will result in a positive adjustment, performance below the threshold will result in a negative adjustment, and performance at the threshold will result in no adjustment. 

The potential percentage adjustment will increase in each period, from 4% in 2019 to 9% in 2022 and subsequent years. The individually applicable percentage adjustments will be linearly scaled based on performance (e.g., in 2019, a score at the threshold will receive no adjustment, a score of 100 will receive a 4% positive adjustment, and a score of 0 will receive a 4% negative adjustment). Additional incentive payments for exceptional performance, in an annual aggregate amount not exceeding $500 million per year through 2024, will be made to those with scores at the 25th percentile of the range between the threshold score and 100, or at the 25th percentile of actual scores above the performance threshold. 

Incentives to Participate in Alternative Payment Models. The Act provides for an annual 5% bonus in calendar years 2019–2024 to physicians who receive a significant portion of revenue through alternative payment models ("APM Participants"). APM Participants also will be exempt from MIPS assessment. The threshold portion of revenues to qualify for the bonus will increase from 25% in 2019–2020, to 50% in 2021–2022, to 75% in 2023–2024. There are two tracks available for meeting the revenue threshold: (i) participation in Medicare alternative payment models (i.e., the shared savings program, a Section 115A innovation model (other than a health care innovation award), or another federal demonstration program); and (ii) participation in a combination of Medicare alternative payment models and alternative arrangements with other payors (either involving participation as a patient-centered medical home, or involving more than nominal downside financial risk). HHS also has flexibility to use patient counts rather than revenue in determining whether the applicable threshold is met. 

Amendment to CMP. A longstanding provision of the CMP penalizes a hospital that knowingly makes payments to physicians as an inducement to reduce or limit services provided to Medicare beneficiaries. The HHS Office of Inspector General ("OIG") has previously interpreted the law to prohibit even payments incentivizing physicians to provide fewer unnecessary services. The Act amends the CMP to include a "medically necessary" qualifier, so as to prohibit payments only if made as inducement to "reduce or limit medically necessary services." The Act also directs HHS, in consultation with OIG, to prepare a report to Congress within one year detailing options for amending fraud and abuse laws to permit worthwhile physician-hospital gainsharing arrangements that would otherwise give rise to civil monetary penalties. 

Other Provisions. In addition, among other provisions, the Act:

  • extends the moratorium on the "two-midnight" rule through September 2015; 
  • revises and delays for one year the scheduled reductions in Medicaid disproportionate share hospital allotments; 
  • continues CHIP through federal fiscal year 2017; 
  • extends funding through federal fiscal year 2017 for community health centers, the national health service corps, teaching health centers, and a variety of other health programs; 
  • provides broader access to Medicare claims data for providers and suppliers, self-insuring employers, health insurance carriers, medical societies and hospital associations, and other HHS-approved entities; 
  • prohibits Medicare supplement plans from providing newly eligible Medicare beneficiaries with full coverage of the Part B deductible; 
  • revises income-based adjustments to Medicare beneficiary premiums beginning in 2018; and 
  • phases in, over a period of not more than four years, a prohibition on the printing of social security numbers on Medicare cards. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Carlton Fields
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Carlton Fields
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions